These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 314114)
41. [Tolerance for antitubercular preparations in the tuberculosis treatment of children and adolescents]. Firsova VA; Mart'ianova EP Probl Tuberk; 1980 Oct; (10):47-51. PubMed ID: 7433447 [No Abstract] [Full Text] [Related]
42. [The neutrophil damage index of children with tuberculosis undergoing chemotherapy combined with tuberculin]. Makhmatov KM; Dzhuraeva RM; Beliakova TIa Probl Tuberk; 1986; (8):56-8. PubMed ID: 3490661 [No Abstract] [Full Text] [Related]
43. [Pyridoxine insufficiency in patients with tuberculosis during antibiotic therapy]. Shmelev NA; Krasheninnikova MA; Klochkova GS; Vil'shanskaia FL; Kozulitsyna TI Klin Med (Mosk); 1974 Dec; 52(12):21-7. PubMed ID: 4444239 [No Abstract] [Full Text] [Related]
44. [Hyaluronidase in complex treatment of tuberculous and metatuberculous lesions of the respiratory organs in children and adolescents]. Kibrik BL; Khitrina GV Probl Tuberk; 1975; (3):48-51. PubMed ID: 1079600 [No Abstract] [Full Text] [Related]
45. [Remote results of treatment of destructive forms of pulmonary tuberculosis in children and adolescents]. Kamenetskaia RA; Kudrinskaia EI; Lapshun GB; Petrukhno AS Probl Tuberk; 1975; (7):43-6. PubMed ID: 1082589 [No Abstract] [Full Text] [Related]
47. Experimental and clinical study on the antituberculous activity of tuberactinomycin-N, a new antibiotic. Toyoara M Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():288-91. PubMed ID: 4468026 [No Abstract] [Full Text] [Related]
51. [Immunological reactivity during the pathogenetic treatment of experimental tuberculosis]. Sibirnaia RI; Snitinskaia OS Vrach Delo; 1990 Feb; (2):77-9. PubMed ID: 2339563 [TBL] [Abstract][Full Text] [Related]
52. Pyrazinamide serum levels in childhood tuberculosis. Thee S; Detjen A; Wahn U; Magdorf K Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511 [TBL] [Abstract][Full Text] [Related]
53. [Long-term results of short course chemotherapy of pulmonary tuberculosis. Second study-B: results at 6 years after the end of 4-9 month chemotherapy of pulmonary tuberculosis]. Baba H; Shinkai A; Izuchi R; Azuma Y Kekkaku; 1987 Oct; 62(10):511-20. PubMed ID: 3444194 [No Abstract] [Full Text] [Related]
54. Quality of life in drug-resistant tuberculosis. Ghoshal AG; Mukherjee K J Assoc Physicians India; 1994 Apr; 42(4):348. PubMed ID: 7860576 [No Abstract] [Full Text] [Related]
55. [Treatment effectiveness in intrathoracic tuberculosis in children and adolescents and the characteristics of the residual posttuberculosis changes]. Berzner AN; German AK; Kovalenbko BA; Kostrub LA; Li BP Probl Tuberk; 1988; (1):32-4. PubMed ID: 3258988 [No Abstract] [Full Text] [Related]
56. [The effect of short-term treatment on the evolution toward chronicity of pulmonary tuberculosis]. Basacopol A; Alexandrescu D; Stanciu M Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):177-9. PubMed ID: 2555905 [No Abstract] [Full Text] [Related]
57. [Nicotinic acid metabolism in patients with pulmonary tuberculosis before therapy and during antibacterial therapy]. Belozorov PT; Vil'nianskiĭ LI; Miroshnikova VI Probl Tuberk; 1967; 45(4):55-9. PubMed ID: 5606806 [No Abstract] [Full Text] [Related]
58. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs]. Reichlin S; Frei R; Reusser P Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152 [TBL] [Abstract][Full Text] [Related]
59. Management of drug resistant tuberculosis. Supcharoen S Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():286-7. PubMed ID: 4468025 [No Abstract] [Full Text] [Related]
60. [Urine 4-pyridoxic acid contents and determination of the acetylation capacity of the organism of children with tuberculosis]. Mirzoev GI Probl Tuberk; 1969; 47(8):30-3. PubMed ID: 5310500 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]